Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients (X-MEN)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2011 by Seoul National University Hospital.
Recruitment status was  Recruiting
Seoul National University Bundang Hospital
Seoul St. Mary's Hospital
Korea University
Bobath Memorial Hospital
Chungang University Hospital
Hanyang University
Kwandong University Myongji Hospital
Inha University Hospital
SungAe General Hospital
Ewha Womans University
Inje University
Hanyang University Seoul Hospital
Kyunghee University Medical Center
Hallym University Medical Center
Pusan National University Hospital
Konyang University Hospital
Wonkwang University Sanbon Medical Center
Yong-in Hyoja Geriatric Hospital
Jeju National University
Dong-A University Hospital
Information provided by:
Seoul National University Hospital Identifier:
First received: October 26, 2010
Last updated: March 8, 2011
Last verified: March 2011
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2011
  Estimated Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)